Q: Hello, my dear wife has been struggling with breast cancer and this site has been a great ray of hope. She has recently been put on a drug called Kisqali (ribociclib). Does anyone know if it is compatible with DCA? Or even complimentary? Do you know of any clinics/practices in Australia competent in administering this drug? I look forward very much to hearing from you. Richard.
A: Hello, Richard.
Unfortunately, Ribociclib (Kisqali) is quite a new therapy against breast cancer and we have found no studies, which discuss of combining it with DCA. However, we’ve reviewed the pharmacodynamics and pharmacokinetics of Ribociclib and it doesn’t look like it should interact badly with Sodium dichloroacetate. In fact, as mentioned before, we have no bad experiences of combining DCA with targeted therapies.
Please read carefully our work at DCA Information and learn all you need before administering DCA to your wife. Everything should be fine. Just don’t overdose the DCA and remember that the protective supplements that we recommend with the DCA protocol are obligatory.
DCA + Kisqali shouldn’t cause any problems when used together. In fact, they could both provide benefits. Another therapy for breast cancer, Tamoxifen, has a synergistic effect with DCA.
If you want real professional help, please contact Dr. Akbar Khan. He has a cancer center in Canada. He’s one of the most famous oncologists who uses DCA with other conventional cancer treatments. We doubt that there is someone better in this field than him.